middle.news

Osteopore Accelerates Growth with 26% Revenue Surge and Strategic Refocus

6:29am on Monday 2nd of June, 2025 AEST Healthcare
Read Story

Osteopore Accelerates Growth with 26% Revenue Surge and Strategic Refocus

6:29am on Monday 2nd of June, 2025 AEST
Key Points
  • 26% QoQ revenue growth to A$725,000 despite South Korean market challenges
  • Craniomaxillofacial and oculoplastic implants listed on Singapore Ministry of Health Implant Subsidy List
  • Early cessation of $18.7 million dental clinical-industrial project to prioritize commercialisation
  • Drawdown of A$2 million from redeemable convertible notes and full repayment of related debt
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about OSTEOPORE (ASX:OSX)
OPEN ARTICLE